Reactive oxygen species and superoxide dismutases: Role in joint diseases

Halliwell, 1992, Free radicals, antioxidants and human disease. Where are we now?, J Lab Clin Med, 119, 598

Henrotin, 2005, Oxygen and reactive oxygen species in cartilage degradation: friends or foes?, Osteoarthritis Cartilage, 13, 643, 10.1016/j.joca.2005.04.002

Henrotin, 2003, The role of reactive oxygen species in homeostasis and degradation of cartilage, Osteoarthritis Cartilage, 11, 747, 10.1016/S1063-4584(03)00150-X

Sakurai, 1995, Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides, J Clin Invest, 96, 2357, 10.1172/JCI118292

Marklund, 1986, Superoxide dismutase isoenzymes of the synovial fluid in rheumatoid arthritis and in reactive arthritides, Ann Rheum Dis, 45, 847, 10.1136/ard.45.10.847

Sandhu, 2003, Distribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, J Rheumatol, 30, 1173

Mathy-Hartert, 2003, Reactive oxygen species downregulate the expression of pro-inflammatory genes by human chondrocytes, Inflamm Res, 52, 111, 10.1007/s000110300023

Goebel, 1981, Intrasynovial orgotein therapy in rheumatoid arthritis, Lancet, 1, 1015, 10.1016/S0140-6736(81)92185-1

Ross, 2004, Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular superoxide dismutase, Arthritis Rheum, 50, 3702, 10.1002/art.20593

Iyama, 2001, Treatment of murine collagen-induced arthritis by ex vivo extracellular superoxide dismutase gene transfer, Arthritis Rheum, 44, 2160, 10.1002/1529-0131(200109)44:9<2160::AID-ART369>3.0.CO;2-0

Salvemini, 2003, Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine, Crit Care Med, 31, S29, 10.1097/00003246-200301001-00005

Halliwell, 1990, Role of free radicals and catalytic metal ions in human disease: an overview, Methods Enzymol, 186, 1, 10.1016/0076-6879(90)86093-B

Haddad, 2002, Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors, Cell Signal, 14, 879, 10.1016/S0898-6568(02)00053-0

Wiseman, 1996, Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer, Biochem J, 313, 17, 10.1042/bj3130017

Bruckdorfer, 1998, Lipid oxidation products and vascular function, Free Radic Res, 28, 573, 10.3109/10715769809065813

Tiku, 1999, Aggrecan degradation in chondrocytes is mediated by reactive oxygen species and protected by antioxidants, Free Radic Res, 30, 395, 10.1080/10715769900300431

Davies, 1987, Protein damage and degradation by oxygen radicals. I. general aspects, J Biol Chem, 262, 9895, 10.1016/S0021-9258(18)48018-0

Stadtman, 1986, Oxidation of proteins by mixed-function oxidation systems: implication in protein turnover, aging and neutrophil function, Trends Biochem Sci, 11, 11, 10.1016/0968-0004(86)90221-5

Johnson, 2005, Superoxide dismutases and their impact upon human health, Mol Aspects Med, 26, 340, 10.1016/j.mam.2005.07.006

McCord, 2005, SOD, oxidative stress and human pathologies: a brief history and a future vision, Biomed Pharmacother, 59, 139, 10.1016/j.biopha.2005.03.005

Orr, 2003, Effects of overexpression of copper–zinc and manganese superoxide dismutases, catalase, and thioredoxin reductase genes on longevity in Drosophila melanogaster, J Biol Chem, 278, 26418, 10.1074/jbc.M303095200

Fujimura, 2000, The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice, J Neurosci, 20, 2817, 10.1523/JNEUROSCI.20-08-02817.2000

Reaume, 1996, Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury, Nat Genet, 13, 43, 10.1038/ng0596-43

Huang, 1997, Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts, Arch Biochem Biophys, 344, 424, 10.1006/abbi.1997.0237

Okado-Matsumoto, 2002, Amyotrophic lateral sclerosis: a proposed mechanism, Proc Natl Acad Sci U S A, 99, 9010, 10.1073/pnas.132260399

Afonso, 2006, TNF-α down-regulates human Cu/Zn superoxide dismutase 1 promoter via JNK/AP-1 signaling pathway, Free Radic Biol Med, 41, 709, 10.1016/j.freeradbiomed.2006.05.014

Morten, 2006, Mitochondrial reactive oxygen species in mice lacking superoxide dismutase 2: attenuation via antioxidant treatment, J Biol Chem, 281, 3354, 10.1074/jbc.M509261200

Wheeler, 2001, Overexpression of manganese superoxide dismutase prevents alcohol-induced liver injury in the rat, J Biol Chem, 276, 36664, 10.1074/jbc.M105352200

Kiningham, 2001, Nuclear factor kappaB-dependent mechanisms coordinate the synergistic effect of PMA and cytokines on the induction of superoxide dismutase 2, Biochem J, 353, 147, 10.1042/0264-6021:3530147

Marklund, 1982, Human copper-containing superoxide dismutase of high molecular weight, Proc Natl Acad Sci U S A, 79, 7634, 10.1073/pnas.79.24.7634

Fattman, 2003, Extracellular superoxide dismutase in biology and medicine, Free Radic Biol Med, 35, 236, 10.1016/S0891-5849(03)00275-2

Enghild, 1999, The heparin-binding domain of extracellular superoxide dismutase is proteolytically processed intracellularly during biosynthesis, J Biol Chem, 274, 14818, 10.1074/jbc.274.21.14818

Juul, 2004, Genetically reduced antioxidative protection and increased ischemic heart disease risk: the Copenhagen City Heart Study, Circulation, 109, 59, 10.1161/01.CIR.0000105720.28086.6C

Martel-Pelletier, 1999, Cytokines and their role in the pathophysiology of osteoarthritis, Front Biosci, 4, 694, 10.2741/Martel

Yudoh, 2005, Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function, Arthritis Res Ther, 7, 380, 10.1186/ar1499

Loeser, 2002, Detection of nitrotyrosine in aging and osteoarthritic cartilage: correlation of oxidative damage with the presence of interleukin-1beta and with chondrocyte resistance to insulin-like growth factor 1, Arthritis Rheum, 46, 2349, 10.1002/art.10496

Stralin, 2000, Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells, Atherosclerosis, 151, 433, 10.1016/S0021-9150(99)00427-X

Adachi, 2006, Infliximab neutralizes the suppressive effect of TNF-alpha on expression of extracellular-superoxide dismutase in vitro, Biol Pharm Bull, 29, 2095, 10.1248/bpb.29.2095

Terkeltaub, 1991, Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation, Arthritis Rheum, 34, 894, 10.1002/art.1780340716

Liu-Bryan, 2005, Monosodium urate and calcium pyrophosphate dihydrate (CPPD) crystals, inflammation, and cellular signaling, Joint Bone Spine, 72, 295, 10.1016/j.jbspin.2004.12.010

McCarty, 1983, Crystal populations in human synovial fluid. Identification of apatite, octacalcium phosphate, and tricalcium phosphate, Arthritis Rheum, 26, 1220, 10.1002/art.1780261008

Prudhommeaux, 1996, Variation in the inflammatory properties of basic calcium phosphate crystals according to crystal type, Arthritis Rheum, 39, 1319, 10.1002/art.1780390809

Reuben, 2002, Molecular mechanism of the induction of metalloproteinases 1 and 3 in human fibroblasts by basic calcium phosphate crystals. Role of calcium-dependent protein kinase C alpha, J Biol Chem, 277, 15190, 10.1074/jbc.M200278200

Dai, 2003, Amelioration of antigen-induced arthritis in rats by transfer of extracellular superoxide dismutase and catalase genes, Gene Ther, 10, 550, 10.1038/sj.gt.3301916

Ugur, 2004, Correlation between soluble intercellular adhesion molecule 1 level and extracellular superoxide dismutase activity in rheumatoid arthritis: a possible association with disease activity, Scand J Rheumatol, 33, 239, 10.1080/03009740310004054

Mazieres, 1991, A French controlled multicenter study of intraarticular orgotein versus intraarticular corticosteroids in the treatment of knee osteoarthritis: a one-year followup, J Rheumatol Suppl, 27, 134

Cuzzocrea, 2001, Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury, Pharmacol Rev, 53, 135

Cuzzocrea, 2000, Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis, Arthritis Rheum, 43, 320, 10.1002/1529-0131(200002)43:2<320::AID-ANR11>3.0.CO;2-9

Muscoli, 2003, On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies, Br J Pharmacol, 140, 445, 10.1038/sj.bjp.0705430

Cuzzocrea, 2005, Synergistic interaction between methotrexate and a superoxide dismutase mimetic: pharmacologic and potential clinical significance, Arthritis Rheum, 52, 3755, 10.1002/art.21480